Keyphrases
Early Detection
100%
Hepatocellular Carcinoma
100%
Genetic Mapping
100%
5-hydroxymethylcytosine (5hmC)
100%
Non-invasive Approach
100%
Cell-free DNA (cfDNA)
100%
Early Hepatocellular Carcinoma
37%
Diagnostic Model
37%
Liver Cirrhosis
25%
Healthy Individuals
25%
Area under the Curve
25%
Validation Set
25%
Clinical Application
12%
Liver
12%
Highly Sensitive
12%
Major Contributor
12%
Genome-wide Distribution
12%
Poor Outcome
12%
DNA Samples
12%
Diagnostic Approach
12%
High-risk Individuals
12%
Diagnostic Biomarker
12%
High Capacity
12%
Potential Confounders
12%
Alcohol Intake
12%
Feature Selection
12%
Alpha-fetoprotein
12%
Small Tumor
12%
Superior Performance
12%
Early Tumor
12%
High-risk Subjects
12%
Case-control Analysis
12%
Benign Liver Lesions
12%
Barcelona Clinic Liver Cancer
12%
Non-invasive Diagnostics
12%
Chinese Subjects
12%
Chronic Hepatitis B Virus Infection
12%
Gene Diagnostics
12%
Elastic Net Regularization
12%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
5 Hydroxymethylcytosine
100%
Cell-Free DNA
100%
Liver Cirrhosis
18%
Neoplasm
9%
Biological Marker
9%
Cancer Staging
9%
Liver Injury
9%
Enhancer Region
9%
Alcohol Consumption
9%
Liver Cancer
9%
Fetoprotein
9%
Chronic Hepatitis B
9%
Non-Invasive Diagnostics
9%
Feature Extraction
9%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
5 Hydroxymethylcytosine
100%
Liver Cirrhosis
18%
Biological Marker
9%
Liver Injury
9%
Liver Cancer
9%
Chronic Hepatitis B
9%
Fetoprotein
9%
Neoplasm
9%
Cancer Staging
9%
Biochemistry, Genetics and Molecular Biology
5-Hydroxymethylcytosine
100%
Enhancer Region
16%
Hepatitis B Virus
16%
Cancer Staging
16%
Feature Extraction
16%
Diagnostic Biomarker
16%